<DOC>
	<DOCNO>NCT01564316</DOCNO>
	<brief_summary>Using method Proteomics , aim conquer intractable disease , try access variety experiment . Biomarker necessary develop new diagnosis method target treatment .</brief_summary>
	<brief_title>Proteomics Study Serum Platelet With Neurodegeneration Disease Patients</brief_title>
	<detailed_description>Following Seoul National University Hospital Institutional Review Board approval , obtain serum platelet neurodegeneration patient control group visit part neurology , 'll analysis differentiate disease use method Proteomics . Biomarker screen via 1D/2D analysis , Mass analysis , database searching- MASCOT search tool , SWISS-PROT etc .</detailed_description>
	<mesh_term>Nerve Degeneration</mesh_term>
	<criteria>neurodegeneration patient control group include dementia patient visit part neurology . age 18 participant understand subject study Total point Mini Mental state exam ( MMSE ) Under 26 include MCI ( mild cognitive impairment ) GDS score 3points . exclusion criterion : eighteen year age participant understand subject study accept study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>